Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.0667
-0.5133 (-88.50%)
Sep 24, 2026, 4:00 PM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $653.63 thousand as of September 25, 2026. Its market cap has decreased by -51.46% in one year.
Market Cap
653.63K
Enterprise Value
18.80M
Revenue
1.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
ChartMarket Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 653.63K, an increase of 158.42%. That is a compound annual growth rate of 6.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 653.63K | -33.66% |
| Dec 31, 2025 | 985.22K | -89.92% |
| Dec 31, 2024 | 9.77M | -38.79% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 7.15M |
| Adaptimmune Therapeutics | 6.89M |
| TRON Group | 6.44M |
| LianMedical | 6.44M |
| Reviva Pharmaceuticals Holdings | 6.29M |
| Hepion Pharmaceuticals | 6.19M |
| Institute of Biomedical Research | 6.05M |
| Pacific Software | 4.98M |